Drug
Indications
Contraindications
Side effects
Dose
Note
Glutamine (alanyl-glutamine and glycine-glutamine)
Critically ill patients (intensive care unit patients, burns, surgical patients)
Bone marrow transplant
Weight loss in patients with AIDS
Cirrhosis or severe liver disease with hepatic encephalopathy
Metabolic acidosis
Renal insufficiency (creatinine clearance <25 mL/min)
Monosodium glutamate sensitivity
Seizures
Increased frequency of high urea levels (>50 mmol/L)
0.35 g/kg intravenously plus
30 g per day enterally
In critically ill patients it increases mortality
References
1.
2.
Robinson MK, Mogensen KM, Casey JD, McKane CK, Moromizato T, Rawn JD, Christopher KB (2015) The relationship among obesity, nutritional status, and mortality in the critically ill. Crit Care Med 43:87–100 [Epub ahead of print]
3.
4.
5.
Rodas PC, Rooyackers O, Hebert C, Norberg Å, Wernerman J (2012) Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 122:591–597CrossRef